Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.55 |
| ▸ | TDO2 | P48775 | 3/20 | 0.55 |
| ▸ | IDO2 | Q6ZQW0 | 2/20 | 0.55 |
| ▸ | ACP3 | P15309 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 5/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.45 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.45 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.45 |
| ▸ | PGR | P06401 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Chlorophenyl-Bisphenylmethane(Major) SCHEMBL29279416 | 0.98 | IDO1 (0.57) | IDO1TDO2IDO2ACP3TSHR | |
| SCHEMBL4481798 | 0.88 | TDP1 (0.56) | IDO1TDO2IDO2ACP3TSHR | |
| SCHEMBL11539630 | 0.88 | SLC6A2 (0.63) | IDO1TDO2IDO2ACP3TSHR | |
| SCHEMBL12221116 | 0.88 | IDO1 (0.46) | IDO1TDO2IDO2ACP3TSHR | |
| SCHEMBL2066643 | 0.84 | TSHR (0.53) | IDO1TDO2IDO2ACP3TSHR | |
| SCHEMBL6556691 | 0.83 | SLC2A1 (0.43) | IDO1TDO2IDO2ACP3TSHR | |
| SCHEMBL13865465 | 0.83 | NR3C1 (0.54) | IDO1TDO2IDO2ACP3TSHR | |
| SCHEMBL7917310 | 0.82 | ALDH1A1 (0.55) | IDO1TDO2IDO2ACP3TSHR | |
| SCHEMBL31409210 | 0.82 | TSHR (0.44) | IDO1TDO2IDO2ACP3TSHR | |
| SCHEMBL10840269 | 0.82 | TSHR (0.40) | IDO1TDO2IDO2ACP3TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4741 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118324658-A | High-yield o-chlorobenzonitrile and production process thereof | 莘县正升化工有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-118307627-A | Epoxy ketone-containing cyclopeptide compound, and preparation method and application thereof | 浙大城市学院 | 2024-07-09 | — | — | CN | claimed |
| WO-2024134676-A1 | PROCESS FOR THE PREPARATION OF TIRZEPATIDE | DR. REDDY’S LABORATORIES LIMITED (IN) | 2024-06-27 | — | — | WO | claimed |
| US-20240209009-A1 | PEPTIDES COMPRISING A PHOSPHORYLCHOLINE CONJUGATE AND METHODS OF SYNTHESIZING SAME | TARSIER PHARMA LTD. (IL) | 2024-06-27 | — | — | US | claimed |
| WO-2024110477-A2 | SYNTHESIS OF A CYCLIC PEPTIDE | JANSSEN PHARMACEUTICA NV (BE) | 2024-05-30 | — | — | WO | claimed |
| US-20240150390-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2024-05-09 | — | — | US | claimed |
| WO-2024081372-A1 | PROCESSES FOR THE PREPARATION OF THE AGENT-LINKER CONJUGATE CL2A-SN-38 AND THE IMMUNOCONJUGATES SACITUZUMAB GOVITECAN AND LABETUZUMAB GOVETICAN | GILEAD SCIENCES, INC. (US) | 2024-04-18 | — | — | WO | claimed |
| WO-2024079043-A1 | METHOD OF MANUFACTURING A PEPTIDE WITH A LYSINE DERIVATIVE | BACHEM HOLDING AG (CH) | 2024-04-18 | — | — | WO | claimed |
| EP-3781586-B1 | A METHOD FOR PRODUCTION OF HIGH PURITY ICATIBANT | FRESENIUS KABI IPSUM S R L (IT) | 2024-04-17 | — | — | EP | claimed |
| US-20240082435-A1 | Solid phase synthesis of glutamate-urea-lysine derived (GUL derived) prostate-specific membrane antigen (PSMA) targeting conjugates and their use as precursors for therapeutic and/or diagnostic agents | TELIX PHARMACEUTICALS (INNOVATIONS) PTY LTD (AU) | 2024-03-14 | — | — | US | claimed |
| WO-1999043694-A1 | IMPROVED METHODS FOR SYNTHESIS OF OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. (US) | 1999-09-02 | — | — | WO | claimed |
| WO-1999043701-A2 | PEPTIDES FOR INHIBITION OF APOPTOSIS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | NST NEUROSURVIVAL TECHNOLOGIES LTD. (IL) | 1999-09-02 | — | — | WO | claimed |
| EP-0918514-A1 | TRIARYL METHANE COMPOUNDS FOR SICKLE CELL DISEASE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1999-06-02 | — | — | EP | claimed |
| WO-1999025347-A2 | CHEMICAL COMPOUNDS HAVING ION CHANNEL BLOCKING ACTIVITY FOR THE TREATMENT OF IMMUNE DYSFUNCTION | NEUROSEARCH A/S (DK) | 1999-05-27 | — | — | WO | claimed |
| EP-0707014-B1 | PROCESS FOR PRODUCING AROMATIC VINYL COMPOUND COPOLYMER | IDEMITSU KOSAN CO (JP) | 1999-02-17 | — | — | EP | claimed |
| US-5817811-A | AMIDATION OF THE CORRESPOND ESTERIFIED AMINE COMPOUND WITH A CARBOXYLATED NUCLEOTIDE BASE | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-10-06 | — | — | US | claimed |
| WO-1997034589-A1 | TRIARYL METHANE COMPOUNDS FOR SICKLE CELL DISEASE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1997-09-25 | — | — | WO | claimed |
| EP-0761681-A2 | Process for the preparation of substituted derivatives of N-ethylglycine | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-03-12 | — | — | EP | claimed |
| EP-0730605-A1 | SUBSTITUTED DI- AND TRIPEPTIDE INHIBITORS OF PROTEIN:FARNESYL TRANSFERASE | WARNER-LAMBERT COMPANY (US) | 1996-09-11 | — | — | EP | claimed |
| WO-1995012612-A1 | SUBSTITUTED DI- AND TRIPEPTIDE INHIBITORS OF PROTEIN:FARNESYL TRANSFERASE | WARNER-LAMBERT COMPANY (US) | 1995-05-11 | — | — | WO | claimed |